IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $722,921 | -4.8% | 427,764 | +56.6% | 0.00% | – |
| Q2 2023 | $759,274 | +18.0% | 273,120 | -22.8% | 0.00% | – |
| Q1 2023 | $643,481 | -89.0% | 353,561 | -69.3% | 0.00% | -100.0% |
| Q4 2022 | $5,839,240 | +107.7% | 1,151,724 | +103.5% | 0.00% | 0.0% |
| Q3 2022 | $2,812,000 | +32.4% | 565,843 | -0.9% | 0.00% | – |
| Q2 2022 | $2,124,000 | -7.2% | 570,840 | +39.9% | 0.00% | – |
| Q1 2022 | $2,290,000 | +43.9% | 408,175 | +56.0% | 0.00% | – |
| Q4 2021 | $1,591,000 | -27.6% | 261,699 | +15.9% | 0.00% | – |
| Q3 2021 | $2,199,000 | -21.6% | 225,747 | +14.9% | 0.00% | -100.0% |
| Q2 2021 | $2,804,000 | +45.6% | 196,407 | +142.1% | 0.00% | – |
| Q1 2021 | $1,926,000 | – | 81,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $4,180,000 | 0.56% |
| HARBOURVEST PARTNERS LLC | 335,709 | $2,041,000 | 0.26% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $586,000 | 0.20% |
| SHEETS SMITH WEALTH MANAGEMENT | 152,276 | $926,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 129,260 | $786,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 140,551 | $855,000 | 0.09% |
| Virtus ETF Advisers LLC | 28,969 | $176,000 | 0.07% |
| XTX Topco Ltd | 19,159 | $116,000 | 0.07% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 49,464 | $301,000 | 0.04% |
| Vident Investment Advisory, LLC | 168,476 | $1,024,000 | 0.03% |